Skip to main content
. 2016 Feb 2;19(1):20504. doi: 10.7448/IAS.19.1.20504

Table 3.

Effects of either cobicistat or ritonavir-boosted protease inhibitors on tenofovir pharmacokinetics [3538]

Effect on tenofovir

Drug Cmax AUC Cmin
Cobicistat 1.34 (1.34 to 1.78) 1.23 (1.16 to 1.38) 1.25 (1.16 to 1.36)
Lopinavir/r 1.15 (1.07 to 1.22) 1.32 (1.25 to 1.38) 1.51 (1.37 to 1.66)
Atazanavir/r 1.34 (1.20 to 1.51) 1.37 (1.30 to 1.45) 1.29 (1.21 to 1.36)
Darunavir/r 1.24 (1.08 to 1.42) 1.22 (1.10 to 1.35) 1.37 (1.19 to 1.57)

Geometric mean ratio (90% confidence intervals).